Brazil's health regulator allows resumption of Chinese vaccine trial

By Reuters

Brazil's health regulator Anvisa announced on Wednesday the resumption of clinical Phase III trials for China's Sinovac COVID-19 vaccine. Anvisa on Monday suspended the trials of the Sinovac vaccine after the death of a volunteer that was registered as a suicide. “After evaluating the new data presented by the sponsor… Anvisa understands that it has sufficient reasons to allow the resumption of vaccination,” the agency's statement said.

…read more

Via:: Sports Headlines

      

Get 20% off hat purchases for ONLY $5! Join our LIDS Club @ lids.com.
%d bloggers like this: